151 results on '"Herzog, Jeremy"'
Search Results
2. Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment
3. Giardia hinders growth by disrupting nutrient metabolism independent of inflammatory enteropathy
4. Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
5. Enhanced mucosal mitochondrial function corrects dysbiosis and OXPHOS metabolism in IBD
6. Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis
7. Mouse Adaptation of Human Inflammatory Bowel Diseases Microbiota Enhances Colonization Efficiency and Alters Microbiome Aggressiveness Depending on Recipient Colonic Inflammatory Environment
8. Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
9. B-Cell Commitment to IL-10 Production: The VertX Il10egfp Mouse
10. Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells
11. Activated Antigen-Presenting Cells Select and Present Chemically Modified Peptides Recognized by Unique CD4 T Cells
12. Merged Supplementary Figures from The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
13. Data from The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
14. Supplementary Figure Legends from The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
15. Gut microbiota induce IGF-1 and promote bone formation and growth
16. Agr2-associated ER stress promotes adherent-invasive E. coli dysbiosis and triggers CD103+ dendritic cell IL-23-dependent ileocolitis
17. Impact of a phage cocktail targeting Escherichia coli and Enterococcus faecalis as members of a gut bacterial consortium in vitro and in vivo
18. Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
19. 611: MUCOSAL METABOLITES FUEL THE GROWTH AND VIRULENCE OF E. COLI LINKED TO CROHN'S DISEASE
20. BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis
21. Sa1880 HUMAN MICROBIOTA-ASSOCIATED MICE: MOUSE-ADAPTED HUMAN IBD MICROBIOTA TRANSPLANT TO COLITIS-SUSCEPTIBLE GERM-FREE MICE INDUCES MORE CONSISTENT, REPRODUCIBLE COLITIS WITH HIGH MICROBIAL TRANSFER EFFICIENCY RELATIVE TO HUMAN FECAL TRANSPLANT
22. Sa1852 ENHANCED EPITHELIAL MITOCHONDRIAL FUNCTION CORRECTS DYSBIOTIC METABOLOMICS IN HUMANIZED IL-10 KO MICE
23. ADHERENT-INVASIVE E. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS
24. ADHERENT-INVASIVEE. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS
25. The Emulsifier Carboxymethylcellulose Induces More Aggressive Colitis in Humanized Mice with Inflammatory Bowel Disease Microbiota Than Polysorbate-80
26. BET protein inhibition regulates macrophage chromatin accessibility and microbiota-dependent colitis
27. 812 PRO-INFLAMMATORY MOLECULAR AND INFLAMMATORY MECHANISMS OF SULFUR METABOLISM IN IBD-RELEVANT CLOSTRIDIUM SPECIES
28. Fr479 IN VIVO CHARACTERIZATION OF SER-301, AN INVESTIGATIONAL RATIONALLY-DESIGNED MICROBIOME THERAPEUTIC FOR PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS
29. PRO-INFLAMMATORY MOLECULAR AND INFLAMMATORY MECHANISMS OF SULFUR METABOLISM IN IBD-RELEVANT CLOSTRIDIA SPECIES
30. Mo1793 AKYLBORONIC ACIDS C2 TO C7 INHIBIT THE GROWTH AND VIRULENCE OF ADHERENT INVASIVE E. COLI LINKED TO CROHN'S DISEASE
31. 562 AUPHOS, A NOVEL DRUG THAT RESTORES INTESTINAL HOMEOSTATIS BY CORRECTING DYSBIOSIS IN INFLAMMATORY BOWEL DISEASES
32. 275 BACTERIAL FUNCTIONAL INTERACTIONS: H2S PROMOTES FUNCTIONAL INTERACTIONS BETWEEN MUCOLYTIC R. GNAVUS AND ADHERENT/INVASIVE E. COLI LF82 RELEVANT TO INTESTINAL INFLAMMATION
33. 125 ABNORMAL BILE ACID PROFILES CONTRIBUTE TO COLITIS INDUCED BY AN AGGRESSIVE SUBSET OF HEALTHY HUMAN BACTERIA
34. 5 USE OF A TARGETED BACTERIOPHAGE COCKTAIL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
35. 425 SUBSETS OF HUMAN RESIDENT BACTERIAL SPECIES THAT DIFFERENTIALLY STIMULATE IL-10 AND IFNγ AND PROTECT VS. INDUCE COLITIS VARIABLY METABOLIZE TAURINE-CONJUGATED BILE ACIDS AND ACTIVATE BILE ACID-MEDIATED HOMEOSTATIC PATHWAYS
36. Sa1906 HUMAN-DERIVED CLOSTRIDIUM VE202 STRAINS REDUCE ENTEROBACTERIACEAE AND FUSOBACTERIA AND REVERSE EXPERIMENTAL COLITIS INDUCED BY HUMAN GUT MICROBIOTA
37. P074 HUMAN-DERIVED CLOSTRIDIUM VE202 STRAINS REDUCE ENTEROBACTERIACEAE AND FUSOBACTERIA AND REVERSE EXPERIMENTAL COLITIS INDUCED BY HUMAN GUT MICROBIOTA
38. Phosphoinositide 3-Kinase P110 delta-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation
39. Yersiniabactin-Producing Adherent/Invasive Escherichia coli Promotes Inflammation-Associated Fibrosis in GnotobioticIl10 −/−Mice
40. Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation
41. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant
42. Yersiniabactin producing AIEC promote inflammation-associated fibrosis in gnotobioticIl10−/−mice
43. Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis
44. 1152 – A Healthy Human Fecal Specimen Includes Multiple E. Coli, Klebsiella Pneumoniae and Enterobacter Strains with Variable Abilities to Activate Th1 Cells and Induce Colitis
45. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
46. Tu1844 - IL-10-Independent Protective Activities of Human-Derived Clostridium Strains in Experimental Colitis
47. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
48. Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice: HEPATOLOGY, VOL. XX, NO. X KANG ET AL
49. Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice
50. 280 The Beneficial Impact of Rifaximin on Systemic and Intestinal Inflammation and Ammonia Occurs Even Without Microbiota: More Than an Antibiotic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.